This study is no longer recruiting participants.
The University of Washington Virology Research Clinic (VRC)/Vaccine & Treatment Evaluation Unit (VTEU) is conducting a clinical trial of a chimpanzee Adenovirus and self-amplifying mRNA prime-boost prophylactic vaccines against SARS-CoV-2 in healthy adults.
The purpose of this trial is to test investigational booster vaccines for COVID-19. Participants who previously received a two-dose series of an mRNA COVID-19 Emergency Use Authorization (EUA) vaccine (Pfizer or Moderna) with a booster will receive a single booster study vaccination. Participants who previously received an adenovirus-vectored COVID-19 EUA vaccine (Johnson and Johnson/Janssen) with a booster will receive a two-dose booster study vaccination series.
Key points:
- We are seeking participants that are 61 years old or older and are in general good health.
- You can only participate if you have been vaccinated against COVID-19 and also received a booster.
- Participation is strictly voluntary.
Payment & Time Commitment:
- You will be compensated $1300-$2000 (depending on what stage/group you are in) for completing all planned study visits.
- The study will last up to 15 months.
If you are interested in participating in this trial, contact us at 206-520-4212 or email us at vteu+gritstone@uw.edu.
See more information on the NIH’s website: ClinicalTrials.gov